Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinically actionable pharmacogenomic variants for anticancer therapy in Nigeria: first comprehensive variant profiling in underrepresented Nigerian cohorts. | BMC Med Genomics | 2026 | 41664142 | PubTator, text mining | PubMed |
| Addressing genetic diversity and health inequities: RELIVAF's proposal for Latin American pharmacogenomic guidelines. | Front Pharmacol | 2026 | 41660507 | PubTator, text mining | PubMed |
| Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis: Their Prevalence, Predictors, and Influence on Early Treatment Outcomes. | J Clin Transl Hepatol | 2026 | 41659999 | PubTator, text mining | PubMed |
| Association between genetically predicted expression of TPMT and azathioprine adverse events. | BMC Pharmacol Toxicol | 2026 | 41654962 | PubTator, text mining | PubMed |
| A near-complete map of human cytosolic degrons and their relevance for disease. | Sci Adv | 2026 | 41650254 | PubTator, text mining | PubMed |
| TPMT-Cisplatin: Lessons in Citation Integrity and Scientific Oversight. | JCO Oncol Pract | 2026 | 41637682 | PubTator, text mining | PubMed |
| Prevalence of TPMT and NUDT15 diplotypes in Mexican children with B-cell acute lymphoblastic leukemia. | Pharmacogenet Genomics | 2026 | 41630471 | PubTator, text mining | PubMed |
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2025 Update. | Clin Pharmacol Ther | 2026 | 41618934 | PubTator, text mining | PubMed |
| Clinical and Economic Impact of Expanded TPMT Testing to Prevent Thiopurine-Induced Myelosuppression in Australia: A Budget Impact Analysis. | Clin Transl Sci | 2026 | 41614408 | PubTator, text mining | PubMed |
| Genetic Determinants of Hematopoietic Toxicity Risk in Thai Pediatric Patients Undergoing 6-Mercaptopurine Treatment. | Clin Transl Sci | 2026 | 41560623 | PubTator, text mining | PubMed |
| Pharmacogenomics of Thiopurine Drugs: A Bench-To-Bedside Success Story in Thailand. | Clin Transl Sci | 2026 | 41555632 | PubTator, text mining | PubMed |
| Beyond rheumatology: Reconsidering methotrexate for Crohn's disease in the biologic era. | World J Gastroenterol | 2026 | 41551829 | PubTator, text mining | PubMed |
| Pharmacotherapy Risks in Rare Genetic Diseases: Cross-Referencing ACMG Secondary Findings v3.2 List With Clinical Databases. | Clin Transl Sci | 2026 | 41527333 | PubTator, text mining | PubMed |
| Role of common host genome variants in Childhood Acute Lymphoblastic Leukemia. | Leukemia | 2026 | 41361660 | PubTator, text mining | PubMed |
| Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between TPMT/NUDT15 and thiopurines. | Eur J Hum Genet | 2026 | 41318725 | PubTator, text mining | PubMed |
| Allopurinol Add-on 6-Mercaptopurine Strategy Improves Efficacy and Reduces Toxicity in Pediatric Patients With Acute Lymphoblastic Leukemia. | Clin Pharmacol Ther | 2026 | 41239552 | PubTator, text mining | PubMed |
| Frequency of thiopurine methyltransferase variants and exploratory predictors of azathioprine-induced leukopenia in Saudi patients with inflammatory bowel disease. | Saudi J Gastroenterol | 2026 | 41190631 | PubTator, text mining | PubMed |
| Inferring germline pharmacogenomics from tumor transcriptome. | Pharmacogenet Genomics | 2026 | 40995674 | PubTator, text mining | PubMed |
| Thiopurine S-methyltransferase (TPMT) activity cutoffs in the Thai population. | Ann Clin Biochem | 2026 | 40919916 | PubTator, text mining | PubMed |
| Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS. | Clin Pharmacol Ther | 2026 | 40908865 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=3